Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE

• Abigél Margit Kolonics-FarkasSemmelweis University
• Martina ŠterclováCharles University
• Nesrin MoğulkoçEge University
• Jan Kuś
• Marta HájkováUniversity Hospital Bratislava
• Veronika MüllerSemmelweis University
• Dragana M. JovanovićUniverzitetski Klinički Centar Srbije
• Jasna Tekavec-TrkanjecUniversity Hospital Dubrava
• Simona LittnerováMasaryk University
• Karel HejdukMasaryk University
• Martina VašákováCharles University